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Departments of Biomedical and Pharmaceutical Sciences and Physics, University of Rhode Island,
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Abstract
Fluorescence spectroscopy was used to study carcinogen-induced conformational heterogeneity in
DNA duplexes. The fluorophore 2-aminopurine (AP) was incorporated adjacent (5′) to the lesion
(G*) in eight different DNA duplexes [d(5′-CTTCTPG*NCCTC-3′):d(5′-GAGGNXTAGAAG-3′),
G* = FAF adduct, P = AP, N = G, A, C, T, and X = C, A] modified by FAF [N-(2′-deoxyguanosin-8-
yl)-7-fluoro-2-aminofluorene], a fluorine-tagged model DNA adduct derived from the potent
carcinogen 2-aminofluorene. Steady-state measurements showed that fluorescence intensity and
Stern–Volmer constants (Ksv) derived from acrylamide quenching experiments decreased for all
carcinogen-modified duplexes relative to the controls, which suggests greater AP stacking in the
duplex upon adduct formation. Conformation-specific stacking of AP with the neighboring adduct
was evidenced by a sequence-dependent variation in fluorescence intensity, position of emission
maximum, degree of emission quenching by acrylamide, and temperature-dependent spectral
changes. The magnitude of stacking was in the order of FAF residue in base-displaced stacked (S)
> minor groove wedged (W) > major groove B type (B). This work represents a novel utility of AP
in probing adduct-induced conformational heterogeneities in DNA duplexes.
Introduction
Conformational heterogeneity is believed to play a role in the structure–function relationships
of carcinogen–DNA adducts (1,2). Although the mechanisms of mutagenesis have been studied
extensively, the conformational aspects underlying replication and repair efficiencies are not
well-understood (3–5). A case in point is the strong hepatocarcinogen N-acetyl-2-
aminofluorene, which reacts with DNA to produce two major C8-substituted dG adducts in
vivo: an aminofluorene (AF)1 adduct [N-(2′-deoxyguanosin-8-yl)-2-aminofluorene] (Figure
1A) and an acetylaminofluorene (AAF) adduct [N-(2′-deoxyguanosin-8-yl)-2-
acetylaminofluorene] (6). The N-deacetylated AF adduct in particular has drawn special
attention because of its ability to adopt uniquely different conformations depending on the
location of the aminofluorene moiety (1,7–12). Three conformations have been characterized
in the duplex setting: the major groove external “B type” (B), the base-displaced “stacked” (S),
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and the minor groove “wedged” (W) conformers (Figure 1B). Small energy differences among
these conformers could shift the adduct population balance at the ss/ds replication fork or in
the active site of a polymerase, making it difficult to delineate structure–function relationships
(13–15).
AF-induced S/B heterogeneity has been implicated in the modulation of sequence-dependent
mutational outcomes. For example, Shibutani et al. (16) showed that the base substitution
mutation of AF in the 5′-GG*C-3′ context is 50-fold higher than in the 5′-TG*C-3′ context in
COS cells. The presence of a dG 5′ to the lesion generally produced a dramatic increase in
overall mutational frequency. Recognition of AF adducts by nucleotide excision repair (NER)
proteins takes place in a conformation-specific manner in Escherichia coli: (i.e., S conformers
appear to be more susceptible to NER than B conformers) (11,12). Furthermore, N-(2′-
deoxyguanosin-8-yl)-7-fluoro-2-aminofluorene (FAF)-induced S/B/W heterogeneity at the
replication fork may influence polymerase function through a long-range distortion effect, thus
contributing to diverse mutational outcomes (10). FAF is a fluorine-tagged AF adduct. FAF-
modified DNA duplexes equilibrate between S and B conformations, and S/B population ratios
are modulated significantly by the 3′-flanking sequence (G > A > C > T).
1H NMR and crystallographic studies have provided detailed atomic resolution views of bulky
DNA adducts (2,3). However, they are not well-suited for studying multiple conformations in
dynamic equilibriums, as is the case for AF. As a remedy, we introduced dynamic 19F nuclear
magnetic resonance (19F NMR) spectroscopy coupled with the fluorine probe FAF (Figure
1A) to study AF-induced conformational heterogeneities in various DNA sequence contexts
(7,11,12). Theoretical calculations showed that both the stacking and the electrostatic
interactions between the carcinogen and the neighboring base pairs are equally important to
the observed sequence effect (12). 19F NMR is a powerful tool but requires a relatively large
sample, thus making it difficult to apply to all types of carcinogen-induced DNA
heterogeneties. Hence, sensitive analytical strategies complementary to NMR that could
provide dynamic conformational information are needed (1).
This study reports the use of the fluorescent probe 2-aminopurine (AP) to investigate AF
heterogeneity in fully paired duplex DNA in a variety of sequence contexts. Although AP has
been used to examine the structure and dynamics of DNA sequencing (17), abasic sites (18),
base flipping (19,20), metal–ion binding (21), and protein–DNA interactions (22), its
application for the study of adduct-induced multiple conformers in DNA duplexes is novel.
Our steady-state measurements indicated that fluorescence intensity, as well as the Stern–
Volmer constant (Ksv) derived from acrylamide quenching, decreased for all carcinogen-
modified duplexes relative to the controls. A sequence-dependent variation in the fluorescence
properties, such as the position of emission maximum, intensity of fluorescence, and degree
of acrylamide quenching, suggested a conformation-specific stacking of AP with the
neighboring adduct. The magnitude of stacking was determined to be in the order of FAF
residue in S > W > B.
Experimental Procedures
Materials and Methods
The AP-containing oligodeoxynucleotides (ODN) were purchased in desalted forms from
Trilink Biotechnologies (San Diego, CA). The corresponding complementary 12-mer ODNs
were purchased in desalted forms from Sigma-Genosys (The Woodlands, TX). A set of AP-
containing control [d(5′-CTTCTPGNCCTC-3′):d(5′-GAGGNXTAGAAG-3′); P = AP; N = G,
A, C, T; and X = C, A] and FAF-modified duplexes [d(5′-CTTCTPG*NCCTC-3′):d(5′-
GAGGNXTAGAAG-3′); G* = FAF adduct; P = AP; N = G, A, C, T, and X = C, A] were
prepared (Table 1) for fluorescence and thermodynamic studies. Chemicals and enzymes such
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as DNase I, phosphodiesterase I, and alkaline phosphatase were all obtained from Sigma
Chemical (Milwaukee, WI). Both 3′- and 5′-phosphodiesterases used in the mass spectrometry
digestion experiments were purchased from Worthington Biochemical (Lakewood, NJ). All
high-performance liquid chromatography (HPLC) solvents were purchased from Fisher
(Pittsburgh, PA).
Preparation of FAF-Modified AP-Containing ODNs
FAF-modified ODNs were prepared using the general procedures described previously.
Typically, an unmodified AP-containing 12-mer ODN was treated with N-acetoxy-N-
trifluoroacetyl-7-fluoro-2-aminofluorene in a pH 6.0 sodium citrate buffer and placed in a
shaker bath for 18 h at 37 °C. Figure 2A shows a reaction HPLC chromatogram for ODN I
sequence 5′-CTTCTPGGCCTC-3′ as an example. The FAF adduct at 26.6 min was isolated
up to >97% purity by repeated injections on reverse phase HPLC. The HPLC system consisted
of a Hitachi EZChrom Elite HPLC unit with a L2450 diode array detector and a Phenomenex
Luna C18 column (150 mm × 10 mm, 5 μm). A 40 min gradient system involving 3–15%
acetonitrile in pH 7.0 ammonium acetate buffer (0.10 M) with a flow rate of 2.0 mL/min was
used.
ESI-TOF-MS Characterization of FAF-Modified AP-Containing ODNs
Electrospray time-of-flight mass spectrometry analysis was carried out to verify the
composition of the five AP-containing ODNs. The ODNs were sequenced using exonuclease
(3′–5′ or 5′–3′) strategies described previously (23,24). Typically, 10 μg of each ODN was
combined with ca. 0.01 units of a 3′–5′ or a 5′–3′ exonuclease in a 1 mM solution of MgCl2
and incubated for 30–60 min. The digests were separated using a Phenomenex Aqua C18 50
mm × 1.0 mm column (particle size, 5 μm; 120 Å). Solvent A was 5 mM in both ammonium
acetate and dimethylbutyl amine. The final pH of the aqueous phase was adjusted to 7.0 using
acetic acid. Solvent B was 0.1% formic acid in acetonitrile. Full-scan, LC-mass spectra were
acquired with digests containing 2 μg of the ODN. Pumps A and B ran in a binary gradient
mode at a flow rate of 200 μL/min. All LC/MS spectra were collected with a Waters LCT time-
of-flight mass spectrometer (Milford, MA) in the negative ion mode. The molecular masses of
the five ODNs in this study were calculated from a weighted average of m/z values derived
from all of the sample-specific signals observed in the full scan mass spectra. The measured
molecular masses of the ODNs were within 0.1 Da of their theoretical masses, and the results
are summarized in Table S1.
Circular Dichroism (CD) Experiments
CD experiments were performed on a Jasco J-810 spectropolarimeter equipped with a variable
temperature controller. Typically, two ODS of AP-containing ODN (I–IV) were dissolved in
400 μL of a buffer containing 0.2 M NaCl, 10 mM sodium phosphate, and 0.2 mM EDTA, pH
7.0, and mixed with an appropriate amount of complementary sequence [dC match (sequence
I–IV) and dA mismatch (sequence V–VIII)]. The sample was heated at 85 °C for 5 min and
then cooled to 15 °C over a 10 min period. All CD measurements were conducted at 15 °C in
a 1 mm path length cell. The spectropolarimeter was scanned from 200 to 400 nm at a rate of
50 nm/min. Data points were acquired every 0.2 nm with a 2 s response time. Spectra were the
averages of 10 accumulations and smoothed using 17 point adaptive smoothing algorithms
provided by Jasco.
UV-Optical Melting Experiments
UV-thermomelting analysis was conducted on a Beckman DU 800 UV/vis spectrophotometer
equipped with a six-chamber, 1 cm path length Tm cell and a built-in Peltier temperature
controller. Duplex solutions with a total concentration in the range of 0.2–14 μm were prepared
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in solutions containing 0.2 M NaCl, 10 mM sodium phosphate, and 0.2 mM EDTA at pH 7.0.
Melting curves were constructed by varying the temperature of the sample cell (1 °C/min) and
monitoring the absorbance of the sample at 260 nm. A typical melting experiment consisted
of two forward and two reverse scans and was repeated three times. Thermodynamic
parameters for bimolecular melting reactions of the duplexes were obtained from melting curve
data using the program MELTWIN version 3.5 as described previously.
Fluorescence Experiments
Steady-state fluorescence emission/excitation spectra of AP-containing ODNs were recorded
on a LS 55 Perkin-Elmer spectrometer consisting of a single cell holder that could be
thermostatted using circulated water. The duplex concentration for each sample was
determined by UV absorption measurements at 260 nm, using the pairwise extinction
coefficients of the constituent nucleotides, and was kept 15 μM for all of the unmodified and
modified duplexes. Measurements were performed in a 10 mm cuvette with 130 μL of sample
solution prepared in buffer containing 0.2 M NaCl, 10 mM sodium phosphate, and 0.2 mM
EDTA at pH 7.0. The emission spectra were recorded over the wavelength range 340–450 nm
with an excitation wavelength of 310 nm, and the excitation spectra were recorded over the
wavelength range 240–330 nm with an emission wavelength of 370 nm. The excitation and
emission slits were fixed at 4.0 and 10.0 nm, respectively, and the scanning speed was
maintained at 500 nm/min. The emission spectrum of an aqueous solution of L-tryptophan
measured in the range of 320–450 nm was used as a standard for the correction of ODN spectra
for the instrument spectral sensitivity.
Fluorescence emission and excitation spectra were measured as a function of temperature for
the unmodified and FAF-modified duplex sequences (I–VIII) from 5 to 45 °C in increments
of 5 °C. Samples were allowed to equilibrate to temperature within the fluorometer before
acquisition of spectra.
Acrylamide Quenching Experiments
Increasing amounts of 5 M acrylamide solution were added to the DNA duplex solutions in
buffer to achieve acrylamide concentrations of 15, 30, 60, 75, 100, 150, 220, 300, and 350 m.
Fluorescence emission/excitation spectra were recorded at each concentration at 15 °C.
Samples were allowed to equilibrate with acrylamide for a minimum of 5 min before the
acquisition of spectra. A dilution correction factor was applied to the final volumes for each
spectral measurement. F0/F, where F0 and F are the corrected fluorescence intensities in the
absence and presence of acrylamide, was plotted against the acrylamide concentrations, and
the slopes were determined by linear regression analysis.
Results
The Experimental System: AP-Containing FAF-Modi-fied ODN
Four AP-containing FAF-modified 12-mer ODN [d(CTTCTPG*NCCTC); G* = FAF adduct;
N = G, A, C, T; and P = AP] were prepared. AP, a fluorescence adenine substitute, was placed
5′ adjacent to the lesion, while the 3′ base flanking the FAF-modified G* was varied
systematically (Figure 1A). These sequences were annealed with the appropriate 12-mer strand,
[d(GAGGNCTAGAAG)] or [d(GAGGNATAGAAG)], to produce the corresponding dC-
matched (I–IV) or dA-mismatched (V–VIII) duplexes, respectively (Figure 1A). The latter
mismatch duplexes were considered because they represent the precursors for G→T
transversion mutations, the most targeted base mutations produced by 2-aminofluorene and
related bulky carcinogens. An identical set of eight unmodified duplexes was also prepared as
controls.
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Synthesis and ESI-TOF-MS Characterization
Figure 2A shows the HPLC profile of a reaction mixture derived from treatment of an
unmodified ODN I (5′-CTTCTPGGCCTC-3′) with an activated 7-fluoro-2-aminofluorene.
The photodiode array UV of the peaks eluting at 26.6 and 27.5 min exhibited low-intensity
shoulders in the 300–350 nm UV range (Figure 2B), which is characteristic for the
aminofluorene chromophore attached at the C8 of dG.
Both modified ODNs (I-1 and I-2) isolated from ODN I reaction mixture were digested with
a 3′-exonuclease and subjected to LC/MS analysis to determine their sequences. 3′-
Exonucleases cleave modified 3′-terminal guanine nucleotides modified by a single
aminofluorene or fluoroaminofluorene group, albeit at a slower rate (8). The 3′-exonuclease
digest fragments are described using the system of nomenclature proposed by McLuckey and
Habibigoudarzi (25). The molecular masses of the five ODNs in this study were calculated
from a weighted average of m/z values derived from all of the sample-specific signals observed
in the full scan mass spectra. The measured molecular masses of the ODNs were within 0.1
Da of their theoretical masses. The results of the molecular mass measurements are summarized
in Table S1. Molecular mass analysis of all 12-mer ODNs studied show that they are modified
by a single FAF group. The molecular mass mass spectrum of the modified ODN I-1 is shown
in Figure 3A. The most prominent ion in the mass spectrum is formed by the loss of three
protons to give a triply charged species (M − 3H)3− at m/z 1255.2. The molecular ion formation
characteristics of all five ODNs were consistent throughout this study.
Briefly, ODNs generated by the sequential removal of single nucleotides from the 3′ terminus
are referred to as B type fragments. The number following the B denotes the number of
individual nucleotides in that particular digest fragment. A B7 ion is an ODN composed of
seven nucleotides. Because the sequence of the ODN being modified is known, we can predict
the m/z values of all of the ions generated from each ODN fragment in the digestion. The m/
z values of each expected ODN fragment may then be plotted in a chromatogram to verify its
presence in a particular digest. Figure 3B is composed of chromatograms of individual ODN
fragments derived from the digest of the first eluting product derived from the reaction of N-
acetoxy-N-trifluoroacetyl-7-fluoro-2-aminofluorene with the ODN, 5′-CTTCTPGGCCTC-3′.
For example, the m/z value of the (M − 3H)3− ion formed by the FAF-modified, B11, ODN
fragment (formed by the cleavage of the terminal cytidine) is expected to be 1158.5. When this
m/z value is plotted vs time, one can see that the B11 fragment elutes at 2.47 min (bottom of
Figure 3B). As the digestion proceeds, smaller fragments composed of 10, nine, eight, and
seven nucleotides will be produced as well. As the number of nucleotides in an ODN fragment
decrease, the charge state associated with individual ions formed during the ESI process is seen
to decrease as well. B8 and B7 ODNs form doubly charged (M − 2H)2− ions predominantly
during the electrospray process. Single ion chromatograms for the (M − 2H)2− ions formed
from the FAF-modified and unmodified B7 fragments are shown at the top of Figure 3B.
Significant abundances of the m/z 1132.7 ion formed from the modified B7 fragment, 5′-
CTTCTPG(FAF)-3′, are observed (3.56 min retention time). The modified B7 fragment is
formed by the removal of the unmodified guanine from the 3′ terminus. The (M − 2H)2− ion
formed from the unmodified B7 ODN, 5′-CTTCTPG-3′, is not observed in this LC/MS
analysis. These observations verify that the position of modification in the sequence 5′-
CTTCTPG(FAF)GCCTC-3′ is the second guanine (G7).
Conformational Compatibility of AP- and A-Containing Duplexes
We demonstrated previously the utility of the FAF fluorine probe for studying the structure–
function relationship of AF adducts (7,12). A H/F swap at the C7 position of the aminofluorene
moiety generally had little effect on the spectroscopic and repair characteristics in different
sequence contexts.
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Similarly, AP has been used as a conformational probe for A in numerous DNA structure
studies. Figure S1 shows a comparison of the normalized CD spectra of FAF-modified AP
with those of the corresponding A-containing duplexes. These sequences are identical except
for the identity of X [d(CTTCTXG*NCCTC), X = AP or A]. The highly intensive CD at around
250 (negative) and 275 nm (positive) represent a typical B-DNA helical conformation. The
induced CD in the 290–360 nm range (ICD290–360nm) is a useful conformational marker for
AF-induced S/B heterogeneity (9). As for duplexes IV, V, and VI, the 275/250 nm and
ICD290–360nm patterns exhibited by AP- and A-containing duplexes were essentially identical,
indicating that replacement of the 5′-A with 2-AP did not change the local adduct conformation.
The remaining five duplexes, although qualitatively similar, showed slight differences in their
profiles. For example, the fluctuating intensities in the ~250 nm region and ICD290–360nm
patterns for the AP-modified duplexes indicate some local perturbation due to small spectral
differences in terms of specific structural/electronic alterations that cannot be interpreted by
CD (26).
The van’t Hoff parameters calculated from the UV-melting curves (Table 1) measure global
duplex dissociation and indicated that both the modified and the control AP-containing
duplexes were destabilized thermodynamically as compared to the A-containing duplexes on
average by ca. 0.7 kcal/mol. A similar trend was observed for Tm with the effect slightly greater
for the modified duplex. These results were not unexpected since AP:T base pairing is not as
stable as the Watson–Crick A:T pairs. A number of previous studies have shown that the AP:T
duplexes exhibit slight reduction of ΔG and Tm relative to the A:T controls but are
conformationally compatible (26). Thus, the AP:A swap in duplexes I–VIII is justified.
Fluorescence Data
The following fluorescence parameters were measured for FAF-modified and unmodified
duplexes at varying temperatures: the relative values of fluorescence quantum yields, the
maximum position of fluorescence spectra, and the extent of quenching of AP emission by
acrylamide. The quantum yield of fluorescence was found to be sensitive to adduct formation
in all duplexes. The FAF-modified DNA duplexes displayed consistently lower fluorescence
as compared to the controls; however, their relative reduction varied significantly (Table 2).
The G*:C matched duplexes I and II, in which the lesion is flanked by a 3′-purine base,
displayed greater reductions in intensity (59–66%) as compared to III and IV, which had a
pyrimidine (2–30%). The G*:A mismatched duplexes V–VIII also exhibited adduct-induced
fluorescence reduction (52–71%), with little sequence-dependent modulation. To ascertain if
observed fluorescence reduction was the outcome of DNA adduct formation, fluorescence of
control duplex was measured by addition of small aliquots of ethanolic solution of FAF. It was
found that the fluorescence of the control duplex remained the same in the absence or presence
of externally added FAF. This confirmed that the decrease in AP fluorescence is essentially
due to its increased stacking in the duplex upon adduct formation with FAF and that FAF is
nonfluorescent. A significant red shift of 6 nm was observed in the position of emission maxima
for duplexes I and II, in which the lesion was flanked by a 3′-purine base. Duplexes III and IV,
with a pyrimidine flanking lesion, exhibited no such shift. The G*:A mismatch duplexes V–
VIII (with the exception of VII) were similarly red-shifted, although the magnitude (4 nm) was
generally smaller than for I and II. This red shift is attributed to reduced solvent exposure
associated with stacking within the duplex.
Acrylamide Quenching and Temperature-Dependent Fluorescence
To gain insight into the local conformation around the lesion site, acrylamide quenching (Table
2) and temperature-dependent fluorescence measurements (Figure 4 and Figure S4) were
conducted. Acrylamide is a fluorescence quencher known to reduce AP fluorescence via
bimolecular collisions (27). The slope of the graph derived from acrylamide quenching
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experiments provides the Stern–Volmer constant (Ksv), which reflects the sensitivity, exposure,
and accessibility of AP toward the quencher. In general, it was found that unmodified controls
experienced greater acrylamide quenching (higher Ksv) than the FAF-modified duplexes (lower
Ksv, Table 2 and Figure S3). A smaller slope for duplexes (I–VIII) upon DNA adduct formation
indicated a smaller acrylamide-dependent change in fluorescence intensity and reduced solvent
exposure of the fluorophore.
Figure 4 shows the temperature-dependent fluorescence spectra of duplex I before and after
FAF modification. Increasing the temperature from 5 to 45 °C led to a rapid increase in
fluorescence intensity of the control duplexes with every 5 °C rise in temperature. An increase
in quantum yield with increased temperature reflects decreased interactions between AP and
its neighboring bases on the primer/template that quench AP fluorescence. In contrast, the FAF-
modified duplexes (I–VIII) showed shallow temperature dependence (Figure S4), revealing
that AP in these modified duplexes is much more stacked and constrained than in the controls.
Furthermore, the increase in temperature led to a short wavelength shift in the position of
fluorescence maximum of FAF-modified I and II. The blue shift at higher temperature is
attributed to changes in base stacking with increased base mobility, leading to increased
exposure of AP to water.
Discussion
Studies have shown that aromatic stacking of AP with other bases gives rise to static quenching
of fluorescence and that base collisions give rise to dynamic fluorescence quenching (28,29).
Static quenching is sensitive to the local equilibrium structure of a DNA and may arise due to
reversible formation of a ground-state binary complex between the fluorophore and the
quencher. A sequence-dependent decrease in fluorescence intensity was observed for duplexes
(I–IV) upon adduct formation. The difference in the quenching of AP fluorescence in duplexes
I, II and III, IV indicates a varied interaction/stacking of the fluorophore with FAF in these
duplexes that is likely governed by flanking sequence effect. AP is an environment-sensitive
fluorophore. Calculations show that changes in the dipole moment between the ground and the
excited states could be up to 3–5 D, which results in a 10–12 nm shift in the position of
fluorescence maximum in environments with different polarities (30). A red shift of 6 and 4
nm was observed in emission maximum of duplexes I/II and V/VI/VIII, respectively, upon
adduct formation. The red shift is diagnostic of stacking interaction of AP with its adjacent
base pairs within the helix and results from reduced solvent exposure (31). Similar shifts in
fluorescent maxima have been reported for PhIP (32) and benzo[a]pyrene (33) when these
carcinogens are stacked with the bases at the lesion site. The shifts might be a result of universal
(dipole–dipole relaxation) and/or specific (formation of H-bonds or other type of stacking)
interactions in the excited state between the fluorophore and the neighboring group during
fluorescence lifetime (28,34). A recent study involving quantum mechanical calculations of
the (AP)T dinucleotide suggests that this shift arises from a perturbed excited-state electronic
structure of AP resulting from a stacked conformation (28).
The reduction of Ksv is not uniform for the controls and might be sequence-specific and also
a function of shielding by the FAF moiety in the W vs B vs S conformers. The decrease in
Ksv derived from acrylamide quenching for all duplexes (I–VIII) upon adduct formation
suggests that the fluorophore becomes more shielded and is probably stacked within the helix
in the modified duplexes. The trend is similar to the decrease in the fluorescence emission of
these duplexes. Because Ksv is proportional to both bimolecular collision rate and lifetime of
excited state, it is quite possible that the shortening of AP lifetime could be a major contributor
in decreasing Ksv than the quenching rate constant. However, it does not rule out that AP is
better stacked in modified duplexes.
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Our steady-state fluorescence investigations reveal that temperature enhances DNA base
motions well below the melting temperature and that these base motions modulate base-
stacking interactions. The temperature-dependent fluorescence study also reveals greater
stacking of AP upon DNA adduct formation. AP fluorescence increased much more rapidly
with increasing temperature for control duplexes than for FAF-modified duplexes.
Furthermore, a short wavelength shift in the position of the fluorescence maximum of FAF-
modified I and II was observed with increasing temperatures. Such a shift in the position of
emission maximum and enhancement of fluorescence is associated with DNA helix melting,
exposure of AP to water, and decreased stacking of AP with neighboring bases or the
carcinogen (30,35). These results indicate that AP is less stacked in the unmodified control
duplexes and adopts a more stacked conformation upon adduct formation.
The present fluorescence results are consistent with the S/B/W population data obtained
by 19F NMR (Table 2) (12). Figure 5A shows the dependence of fluorescence reduction on the
S conformer population. It has been shown that the A-containing FAF duplexes I and II
preferentially adopt the base-displaced stacked S conformation (61–68%) (Figure 5B). This
finding may explain the observed red-shifted emission as well as the significant reductions in
quantum yield and Ksv of duplexes I and II. FAF-modified duplexes III and IV, however, exist
mainly (60–64%) in the B conformation, in which the carcinogen protrudes into the major
groove with very little interaction with AP (Figure 5B). The lack of AP interaction could
explain the less pronounced decrease in quantum yields, no shifts in emission spectrum, and a
relatively small reduction of Ksv as compared to the control duplexes. It should be noted,
however, that a large difference in fluorescence reduction was observed for FAF-modified
duplexes III and IV despite the fact that both adopt nearly identical S/B heterogeneity (Table
2). Duplex III appears to be an anomaly since its quantum yield was considerably low to begin
with and it exhibited virtually no quenching (2%) upon FAF modification. Unlike other
sequences, the control and modified III duplexes exhibited no temperature effect (Figure S4).
These results suggest that the AP in sequence III stacks well in the control duplex and that
adduct formation has no effect on stacking.
According to our 19F NMR results (unpublished data), the FAF-modified mismatch duplexes
V–VIII exclusively adopt a W conformation. Unlike the S conformer, the carcinogen in the W
conformer clashes sterically with the mismatched dA at the lesion site and is pushed into the
minor groove, where it is sandwiched (2,9). As shown in Figure 1B, the aminofluorene moiety
in the W conformer likely exists in a skewed conformation, limiting its interaction with AP.
In contrast, the S conformation places the carcinogen horizontally in the helix, which allows
maximum interactions with AP (Figure 5B), explaining why the red-shift seen in modified
duplexes V, VI, and VIII (4 nm) is between that of I/II (6 nm) and III/IV (no shift).
The current adduct model is unique since AP stacks with either the hydrophobic aromatic
moiety (as in S and W conformers) or the modified guanine base (as in the B conformer),
meaning that the helix is always occupied. This is in contrast to previously studied systems
such as base flipping and abasic sites (21,36), in which AP can stack with either a regular DNA
base or no base. Variations in AP fluorescence observed in this study are unique because they
reflect the subtleties of sequence-dependent dynamic heterogeneity, not a specific
conformational motif. Recent theoretical studies (37) indicate that it is the base stacking of AP,
not the hydrogen bonding, that is a major factor in fluorescence quenching and that the
molecular orbitals involved in fluorescence transition spread over more than one base. The
quenching effect is found to be most pronounced when AP is stacked with a purine base rather
than a pyrimidine base, indicating the importance of extended π-orbital conjugation (38). As
shown in Figure 5B, the 5′-flanking AP in the S conformer duplexes I and II is able to stack
efficiently with the highly electron-rich aminofluorene moiety. The stacking interaction is also
greatly enhanced by the presence of 3′-flanking purine bases, probably for the same reason
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discussed above. Sequence-dependent base stacking and unstacking are enthalpic in nature
(39) and have been shown to be an important determining factor for nucleotide excision repair
by the E. coli UvrABC system (12,20,40,41).
In summary, we have demonstrated the utility of AP in studying carcinogen-induced
conformational heterogeneity in duplex DNA. AP experience conformation-dependent internal
quenching, thus making it a highly efficient fluorophore for probing the microenvironments
of adduct conformers. The S/B population-specific stacking of AP with the neighboring adduct
is evidenced by a sequence-dependent variation in intensity and position of emission maximum
and the degree of emission quenching (Ksv) by acrylamide. The steady-state fluorescence
results indicate that the stacking magnitude of AP with the carcinogen moiety follows the order
of S > W > B conformers. The AP procedure presented in the present study may not give the
exact distribution of conformers but in combination with NMR provides complementary
information about the conformational subtleties of arylamine adducts in the DNA duplex
settings. The next challenge is to monitor adduct-induced conformational heterogeneity in the
presence of a polymerase.
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Figure 1.
(A) Chemical structures of AF and FAF adducts and sequences used in the present study. (B)
The view for three conformational motifs of the AF-modified DNA from the minor groove
side: B, S, and W conformers. The modified dG and the opposite base (dC for B and S
conformers; dA for the W conformer) residues are shown in red and blue lines, respectively,
and the carcinogenic aminofluorene moiety is highlighted with red CPK.
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Figure 2.
(A) HPLC chromatogram of a mixture from reaction of ODN I d(CTTCTPGGCCTC) with
N-acetoxy-N-trifluoroacetyl-4-fluoro-2-aminofluorene. See the Experimental Procedures for
detailed HPLC conditions. (B) Online UV spectra of (a) unmodified 12-mer and (b) early and
(c) late-eluting.
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Figure 3.
(A) LC-TOF/MS spectra of the (ODNI-1) 5′-CTTCTPG(FAF)GCCTC-3′ and the inset
showing the spacing between the isotopic ions in the (M – 3H)3− cluster. (B) LC-TOF/MS
chromatograms of individual ODN fragments derived from 5′-CTTCTPG(FAF)GCCTC-3′
after 80 min of digestion with 3′-PDE.
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Figure 4.
Temperature-dependent fluorescence emission of the control I (A) and FAF-modified I (B)
duplexes. Dotted arrows indicate increments of 5 °C between 5 and 45 °C.
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Figure 5.
(A) Percent fluorescence emission reduction of duplexes I–IV vs %S conformer population
determined from 19F NMR spectroscopy (12). The standard deviations for I, II, III, and IV are
±0.8, 2.6, 1.5, and 0.9% fluorescence reduction, respectively. (B) The major groove views of
the AP/carcinogen stacking interaction using the central trimer segments of the B and S
conformers of duplex II (–AG*A–/–TCT–). The orange-shaded oval indicates the flanking
base 5′ to the adduct G* (A or AP). The modified dG and the complementary dC are shown in
red and green lines, respectively, and the carcinogenic aminofluorene moiety is highlighted
with CPK. The dotted pink arrows indicate the stacking between the AP and the carcinogen.
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